References
- Boraan G, Backer U, Larsson S, Melander B, Wahlander L. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases. Eur J Respir Dis 1983; 64: 405–15
- Harrison P M, Keays R, Bray G P, Alexander G J, Williams R. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet 1990; 335: 1572–3
- Moldeus P, Cotgreave I A, Berggren M. Lung protection by a thiol-containing antioxidant:N-acetylcysteine. Respiration 1986; 50(Suppl 1)31–42
- Jepsen S, Herlevsen P, Knudsen P, Bud M I, Klausen N. Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: A prospective, randomized, placebo-controlled study. Crit Care Med 1992; 20: 918–20
- Langdell R D, Wagner R H, Brinkhous K M. Effect of antihemophilic factor on one stage clotting test. J Lab Clin Invest 1953; 41: 637–47
- Biggs R, MacFarlane R G. Prothrombin and proconvertin method (modified from Owren and AAS, 1951) in human blood coagulation, 3rd ed. Blackwell Scientific Publications, Oxford 1962; 385–8
- Beckett G J, Donovan J W, Hussey A J, Proudfoot A T, Prescott L F. Intravenous N-acetylcysteine, hepatotoxicity and plasma glutathione S-transferase in patients with paracetamol overdosage. Hum Exp Toxicol 1990; 9: 183–6
- Sheffner A L, Medler E M, Bailey K R, Gallo D G, Mueller A J, Sarett H P. Metabolic studies with acetylcysteine. Biochem Pharmacol 1966; 15: 1523–35
- Gilbert H F. Thermodynamic and kinetic constraints on thiol/disulfide exchange involving glutathione redox buffers. Glutathione centennial, N Taniguchi, T Higasini, Y Sakamoto, A Meister. Academic Press Inc, San Diego 1989; 73–89
- Harrison P M, O'Grady J G, Keays R T, Alexander G J, Williams R. Serial prothrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure. BMJ 1990; 301: 964–6